Pancreatic cancer and adaptive metabolism in a nutrient-deficient environment
| Autor: | Sylwia Małgorzata Słotwińska, Robert Słotwiński |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Chemotherapy
Review Paper autophagy pancreatic carcinoma business.industry macropinocytosis medicine.medical_treatment Immunology Autophagy Cancer adaptive metabolism mucins medicine.disease Metabolic pathway Pancreatic cancer Cancer cell Cancer research Immunology and Allergy Medicine Signal transduction business Survival rate |
| Zdroj: | Central-European Journal of Immunology |
| ISSN: | 1644-4124 1426-3912 |
| Popis: | Despite tremendous progress in the treatment of many cancer types, leading to a significant increase in survival, pancreatic ductal adenocarcinoma (PDAC) is still burdened with high mortality rates (5-year survival rate < 9%) due to late diagnosis, aggressiveness, and a lack of more effective treatment methods. Early diagnosis and new therapeutic approaches based on the adaptive metabolism of the tumor in a nutrient-deficient environment are expected to improve the future treatment of PDAC patients. It was found that blocking selected metabolic pathways related to the local adaptive metabolic activity of pancreatic cancer cells, improving nutrient acquisition and metabolic crosstalk within the microenvironment to sustain proliferation, may inhibit cancer development, increase cancer cell death, and increase sensitivity to other forms of treatment (e.g., chemotherapy). The present review highlights selected metabolic signaling pathways and their regulators aimed at inhibiting the neoplastic process. Particular attention is paid to the adaptive metabolism of pancreatic cancer, including fatty acids, autophagy, macropinocytosis, and deregulated cell-surface glycoproteins, which promotes cancer cell development in an oxygen-deficient and nutrient-poor environment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|